|Day Low/High||0.44 / 0.51|
|52 Wk Low/High||0.37 / 6.44|
Conference Call to be Held at 4:30 p.m. ET (1:30 p.m. PT)
Invention further streamlines ThermoGenesis' CAR-TXpress workflow, improving efficiency and reducing costs
Management to host conference call at 4:30pm ET
Intellectual Property Position Surrounding the Company's X-BACS Technology is Significantly Strengthened
Conference Call to be Held at 4:30 p.m. EST (1:30 p.m. PST)
Conference Call to be Held at 4:30 p.m. EDT (1:30 p.m. PDT)
And a management shakeup helps push down NuVasive.
Next-generation automated technology isolates and harvests rare cell types with superior purity, recovery, and viability, and is well suited to the high production demands of immunotherapy drugs
Combined product portfolio strengthens Cesca's position as a leading developer of systems for automated manufacturing of cell-based therapeutics in immuno-oncology and other indications
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.